Quercetin HPLC98% umgangatho umgangatho USP40

Nazi ezinye iingxelo zophando zamva nje malunga nokusetyenziswa kwe-quercetin

1.I-Quercetin iphucula isibindi esinamafutha: Ngomhla we-19 kaJulayi, i-2024, iqela lophando kwi-Army Medical University lipapashe impumelelo yophando kwi-American Journal of Clinical Nutrition. Baye baqhuba uvavanyo lwekliniki olungahleliwe, oluphindwe kabini, oluyimfama, lwe-placebo olubandakanya izigulane ze-41 ezine-non-alcoholic fatty disease (NAFLD). Izigulane zathatha i-500 milligrams ye-quercetin okanye i-placebo imihla ngemihla kwiiveki ze-12, kwaye amaqela amabini atshintshe amanyathelo okungenelela kwezinye iiveki ze-12. Iziphumo zibonise ukuba i-fat fat content yezigulane kwiqela le-quercetin yehla kakhulu, kunye nokunciphisa okuphakathi kwe-17.4%, ngelixa iqela le-placebo liyancipha kuphela nge-0.9%. Okwangoku, ubunzima bomzimba kunye ne-BMI yezigulane kwiqela le-quercetin nazo zehla kakhulu. Ngaphezu koko, ukuncitshiswa kwamafutha esibindi kwizigulane zabasetyhini kwakumalunga nokuphindwe kabini kwizigulane zamadoda. Akukho miphumo emibi ye-quercetin kwindlela yegazi, umsebenzi wezintso, kunye noxinzelelo lwegazi lwabathathi-nxaxheba babonwa ngexesha lokufunda.

2.I-Quercetin inciphisa ukutyeba: NgoJanuwari 31, 2025, iqela lophando elikhokelwa nguWang Xinxia waseYunivesithi yaseZhejiang lipapashe inqaku elinesihloko esithi "Quercetin - Driven Akkermansia Muciniphila Unciphisa Ukutyeba ngokuModulating Bile Acid Metabolism ngeILA / m6A / CYP8B1 Signaling" = Adv Sci4 (3). Uphononongo lufumene ukuba i-quercetin - eqhutywa yi-Akkermansia muciniphila inciphisa ukutyeba ngokulawula i-bile acid metabolism ngokusebenzisa i-indole - i-3 - i-lactic acid (ILA) / m6A / CYP8B1 indlela yokubonisa. I-Quercetin inokuphucula i-high-fat - diet - i-induced osity-induced disorders kunye nokuphazamiseka kwe-metabolic ehambelanayo, ukubunjwa kwakhona kwesakhiwo se-microbiota, kunye nokunyusa ubuninzi be-Akkermansia muciniphila. Le bhaktheriya ityebisa kwaye ivelise i-ILA engaphezulu, ephezulu - ilawula ukubonakaliswa kwe-CYP8B1 ngendlela ye-FTO / m6A / YTHDF2, ikhuthaza ukuguqulwa kwe-cholesterol kwi-cholic acid, kwaye emva koko isebenze i-farnesoid X receptor kwi-adipose tissue inhibit lipid accumulation.